CIK 0001656472 · Accelerated filer
Cronos Group Inc.
Sign in to watch- Ticker
- CRON
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (416) 504-0004
- Business address
- 4491 CONCESSION RD 12, STAYNER, Ontario, Canada, L0M 1S0
- Former names
- PharmaCan Capital Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-16 | GORENSTEIN MICHAEL RYAN Executive Chairman | Option exercise | +103,125 | $6.07 | $626K | 9,510,939 |
| 2021-03-16 | GORENSTEIN MICHAEL RYAN Executive Chairman | Shares withheld for taxes | −70,427 | $10.70 | $753K | 9,440,512 |
| 2021-03-16 | GORENSTEIN MICHAEL RYAN Executive Chairman | Option exercise · COMMON SHARE OPTION (right to buy) | −437,500 | 62,500 | ||
| 2021-03-16 | GORENSTEIN MICHAEL RYAN Executive Chairman | Option exercise · COMMON SHARE OPTION (right to buy) | −1,272,916 | 27,084 | ||
| 2021-03-16 | GORENSTEIN MICHAEL RYAN Executive Chairman | Option exercise · COMMON SHARE OPTION (right to buy) | −103,125 | 46,875 | ||
| 2021-03-15 | ADLER JASON MARC Director | Sale | −452,810 | $10.65 | $4.8M | 8,879,831 |
| 2021-03-15 | GORENSTEIN MICHAEL RYAN Executive Chairman | Sale | −130,000 | $10.73 | $1.4M | 8,432,536 |
| 2021-03-12 | ADLER JASON MARC Director | Option exercise | +83,334 | $0.40 | $33K | 5,562,426 |
| 2021-03-12 | ADLER JASON MARC Director | Shares withheld for taxes | −3,179 | $10.39 | $33K | 5,559,247 |
| 2021-03-12 | ADLER JASON MARC Director | Option exercise | +1,200,000 | $0.97 | $1.2M | 6,759,247 |
| 2021-03-12 | ADLER JASON MARC Director | Shares withheld for taxes | −112,586 | $10.39 | $1.2M | 6,646,661 |
| 2021-03-12 | ADLER JASON MARC Director | Option exercise | +2,737,132 | $0.19 | $531K | 9,383,793 |
| 2021-03-12 | ADLER JASON MARC Director | Shares withheld for taxes | −51,152 | $10.39 | $531K | 9,332,641 |
| 2021-03-12 | ADLER JASON MARC Director | Option exercise | +1,250,000 | $0.19 | $243K | 1,250,000 |
| 2021-03-12 | ADLER JASON MARC Director | Shares withheld for taxes | −23,361 | $10.39 | $243K | 1,226,639 |
| 2021-03-12 | ADLER JASON MARC Director | Option exercise · COMMON SHARE OPTION (right to buy) | −83,334 | 0 | ||
| 2021-03-12 | ADLER JASON MARC Director | Option exercise · COMMON SHARE OPTION (right to buy) | −1,200,000 | 0 | ||
| 2021-03-12 | ADLER JASON MARC Director | Option exercise · WARRANTS | −2,737,132 | 0 | ||
| 2021-03-12 | ADLER JASON MARC Director | Option exercise · WARRANTS | −1,250,000 | 0 | ||
| 2021-03-12 | GORENSTEIN MICHAEL RYAN Executive Chairman | Sale | −150,000 | $10.35 | $1.6M | 8,562,536 |
Page 28 of 31 · 605 trades